“We are heartened to see that progress against tuberculosis (TB) has started to rebound after several years of increased numbers […]
The 2023 United Nations (UN) High-Level Meeting (HLM) on Tuberculosis (TB) saw world leaders come together to commit to increased
TB Alliance wholeheartedly supports the commitment made today at the United Nations High-Level Meeting on Tuberculosis (TB) to fight this
NEW YORK (September 15, 2023) — Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project — have updated their
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
NEW YORK (August 10, 2023)—Non-profit drug developer TB Alliance has granted Remington Pharmaceutical Industries (Pvt.) Ltd. a non-royalty bearing license
NEW YORK (July 28, 2023)—TB Alliance applauds all efforts to expand access responsibly to lifesaving TB technologies. Stimulating market competition
“The addition of pretomanid to the Essential Medicines List (EML) of the World Health Organization (WHO) is a critical step
BERLIN (7 July 2023)—The German Federal Ministry of Education and Research (BMBF) through KfW has granted funding to five non-profit
NEW YORK (May 17, 2023)—TB Alliance today announces that it will receive up to $3.9 million from the Cystic Fibrosis
